Mannatech (NASDAQ:MTEX) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEXGet Rating) in a report issued on Monday. The firm set a “buy” rating on the stock.

Separately, TheStreet raised shares of Mannatech from a “c+” rating to a “b-” rating in a report on Thursday, October 13th.

Mannatech Trading Up 2.5 %

Shares of Mannatech stock opened at $22.40 on Monday. The company has a market capitalization of $41.64 million, a P/E ratio of 9.91 and a beta of 1.12. The company’s fifty day moving average is $21.55 and its two-hundred day moving average is $21.71. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.74 and a current ratio of 1.27. Mannatech has a 1 year low of $15.49 and a 1 year high of $40.38.

Hedge Funds Weigh In On Mannatech

A hedge fund recently raised its stake in Mannatech stock. LSV Asset Management increased its position in Mannatech, Incorporated (NASDAQ:MTEXGet Rating) by 1,090.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,142 shares of the company’s stock after buying an additional 6,542 shares during the period. LSV Asset Management owned about 0.37% of Mannatech worth $261,000 as of its most recent SEC filing. 23.74% of the stock is owned by hedge funds and other institutional investors.

About Mannatech

(Get Rating)

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels.

Read More

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.